| Literature DB >> 25849802 |
Elena Pahonțu1, Diana-Carolina Ilieș2,3, Sergiu Shova4, Codruța Paraschivescu5, Mihaela Badea6, Aurelian Gulea7, Tudor Roșu8.
Abstract
A novel Schiff base,Entities:
Mesh:
Substances:
Year: 2015 PMID: 25849802 PMCID: PMC6272500 DOI: 10.3390/molecules20045771
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Schiff base ligand (HL).
Figure 2Proposed structures for the copper(II) complexes 1–5.
Figure 3X-ray molecular structure of (HL). Thermal ellipsoids are drawn at 50% probability level. H-bond parameters: O3−H∙∙∙N1 [O3−H 0.86 Å, H∙∙∙N1 1.87 Å, O3∙∙∙N1 2.602(2) Å, O3−H∙∙∙N1 140.7°].
Figure 4π-π staking interactions in the crystal structure (HL).
Figure 5View of the supramolecular ribbon in the crystal structure (HL). C17−H∙∙O2 [C17−H 0.96 Å, H∙∙∙O2 2.44 Å, C17∙∙∙O2(−x, −1 + y, 1.5 – z) 3.378(4) Å, C17−H∙∙∙O2 164.4°].
Selected bond lengths (Å) and bond angles (°) for HL.
| Bond Lengths (Å) for HL | Bond Angles (°) for HL | ||
|---|---|---|---|
| O1-C2 | 1.445(2) | C3-O1-C2 | 116.8(2) |
| O1-C3 | 1.343(2) | O1-C2-C1 | 107.4(2) |
| O2C3 | 1.210(2) | O1-C3-C4 | 112.4(2) |
| O3-C12 | 1.349(2) | O2-C3-O1 | 122.7(2) |
| O4-C14 | 1.363(2) | O2-C3-C4 | 124.9(2) |
| O4-C17 | 1.425(2) | C6-C7-N1 | 116.7(2) |
| N1-C7 | 1.411(2) | C8-C7-N1 | 125.0(2) |
| N1-C10 | 1.284(2) | C10-N1-C7 | 122.0(2) |
| C12-C13 | 1.386(2) | N1-C10-C11 | 122.3(2) |
| C13-C14 | 1.382(2) | O3-C12-C11 | 121.1(2) |
| O3-C12-C13 | 118.3(2) | ||
| O4-C14-C13 | 124.7(2) | ||
| O4-C14-C15 | 114.5(2) | ||
| C14-O4-C17 | 117.6(2) | ||
Selected bond lengths (Å) and bond angles (°) for compound 6.
| Cu1-S1 | 2.406(2) | Cl1-O17 | 1.363(7) |
| Cu1-O9 | 1.952(4) | Cl1-O20 | 1.374(6) |
| Cu1-O5 | 1.941(4) | Cl1-O18 | 1.375(7) |
| Cu1-O1 | 2.244(4) | Cl1-O19 | 1.42(1) |
| Cu1-N3 | 1.957(5) | O5-C23 | 1.324(7) |
| Cu2-S2 | 2.404(2) | C6-O1 | 1.282(7) |
| Cu2-O9 | 1.947(4) | N2-C25 | 1.317(8) |
| Cu2-O5 | 1.965(4) | N2-C26 | 1.409(8) |
| Cu2-N2 | 1.956(5) | N3-C43 | 1.423(9) |
| Cu2-O13 | 2.323(4) | O13-C57 | 1.292(7) |
| Cu2-O1 | 2.356(6) | S1-C7 | 1.769(6) |
| S2-C41 | 1.786(6) | S1-C24 | 1.788(6) |
| S2-C58 | 1.777(6) | O9-C40 | 1.320(7) |
| O9-Cu1-S1 | 161.5(1) | O5-Cu2-O1W | 92.1(2) |
| O9-Cu1-O1 | 99.5(2) | N2-Cu2-S2 | 105.4(2) |
| O9-Cu1-N3 | 92.1(2) | N2-Cu2-O5 | 92.4(2) |
| O5-Cu1-S1 | 84.1(1) | N2-Cu2-O13 | 87.9(2) |
| O5-Cu1-O9 | 77.6(2) | N2-Cu2-O1W | 95.9(2) |
| O5-Cu1-O1 | 91.9(2) | O13-Cu2-S2 | 76.8(1) |
| O5-Cu1-N3 | 169.7(2) | O13-Cu2-O1W | 169.4(2) |
| O1-Cu1-S1 | 78.1(1) | O1W-Cu2-S2 | 92.6(2) |
| N3-Cu1-S1 | 106.1(2) | Cu2-O9-Cu1 | 101.9(2) |
| N3-Cu1-O1 | 88.8(2) | Cu1-O5-Cu2 | 101.7(2) |
| O9-Cu2-S2 | 84.6(1) | O17-Cl1-O20 | 108.8(5) |
| O9-Cu2-O5 | 77.2(2) | O17-Cl1-O18 | 113.2(6) |
| O9-Cu2-N2 | 168.8(2) | O17-Cl1-O19 | 104.4(8) |
| O9-Cu2-O13 | 89.4(2) | O20-Cl1-O18 | 114.7(4) |
| O9-Cu2-O1W | 88.7(2) | O20-Cl1-O19 | 107.7(6) |
| O5-Cu2-S2 | 161.0(1) | O18-Cl1-O19 | 107.3(6) |
| O5-Cu2-O13 | 97.6(2) | ||
Figure 6The X-ray structure of the complex cation [Cu2(L2S)2(ClO4)(H2O)]+ (6). H-bonds parameters: N1−H∙∙∙O1 [N1−H 0.86 Å, H∙∙∙O1 1.79 Å, N1∙∙∙O1 2.526(7) Å, N1−H∙∙∙O1 141.7°]. N4−H∙∙∙O13 [N1−H 0.85 Å, H∙∙∙O13 1.80 Å, N4∙∙∙O13 2.522(7) Å, N4−H∙∙∙O13 140.0°]. O1w−H∙∙∙O19 [N1−H 0.85 Å, H∙∙∙O19 1.93 Å, O1w ∙∙∙O19 2.74(1) Å, O1w−H∙∙∙O19 161.3°].
Figure 7Structure of the two ligands (L2S) in the complex cation [Cu2(L2S)2(ClO4)(H2O)]+.
Figure 8The coordination mode for the copper atoms of in the binuclear complex [Cu2(L2S)2(ClO4) (H2O)]+.
Figure 9View of 2D supramolecular layer in the crystal structure 6.
Electronic spectra (cm−1) and magnetic moments (BM) of the complexes 1–5.
| Metal Complex | Transitions d–d (cm−1) | µeff (BM) | Geometry | ||
|---|---|---|---|---|---|
| [Cu(L)(NO3)(H2O)2] ( | 2B1g→2A1g2 10,500 | 2B1g→2B2g 13,420 | 2B1g→2Eg 19,400 | 1.98 | Octahedral distorted |
| [Cu(L)2] ( | 2B2→2E 11,100 | 2B2→2B1(2A1) 13,100 | - | 1.87 | Pseudo-tetrahedral |
| [Cu(L)(OAc)] ( | 2B2→2E 10,980 | 2B2→2B1(2A1) 13,500 | - | 1.92 | Pseudo-tetrahedral |
| [Cu2 (L)2Cl2(H2O)4] ( | 2B1g→2A1g 11,000 | 2B1g→2B2g 12,820 | 2B1g→2Eg 16 940 | 1.07 | Octahedral distorted |
| [Cu(L)(ClO4)(H2O)] ( | 2B2→2E 9850 | 2B2→2B1(2A1) 12,200 | - | 1.90 | Pseudo-tetrahedral |
EPR spectral parameters of the copper(II) complexes 1–5.
| 1 | 2 | 3 | 4 | 5 | |
|---|---|---|---|---|---|
| Polycrystalline (298K) | |||||
| 2.230 | - | - | 2.132 | - | |
| g⊥ | 2.060 | - | - | 2.059 | - |
| giso | - | 2.097 | 2.102 | - | 2.127 |
| DMSO (77 K) | |||||
| 2.400 | 2.290 | 2.289 | 2.239 | 2.282 | |
| g⊥ | 2.078 | 2.075 | 2.065 | 2.055 | 2.060 |
| Aǁ | 117.0 | 162.0 | 150.2 | 170.0 | 170.0 |
| α2 | 0.802 | 0.800 | 0.779 | 0.772 | 0.817 |
| β2 | 0.997 | 0.948 | 0.990 | 0.990 | 0.887 |
| δ2 | 0.862 | 0.958 | 0.922 | 0.950 | 0.801 |
| Kǁ | 0.800 | 0.755 | 0.762 | 0.770 | 0.718 |
| K⊥ | 0.692 | 0.760 | 0.715 | 0.735 | 0.658 |
Figure 10EPR spectra for the complexes 2, 3 and 5 in powder, at room temperature.
Figure 11EPR spectrum of the complex 1, in DMSO solution, registered at 77 K and (d2) second derivative spectra.
Figure 12EPR spectrum (the derived signal) for complex 5 in DMSO solution at 77.
Figure 13EPR spectrum of the complex 4, in solution, at room temperature and 77 K.
Antibacterial activities of ligand HL and complexes 1–5 as MIC a/MBC b values (mg/mL).
| Compounds | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| MIC | MBC | MIC | MBC | MIC | MBC | MIC | MBC | MIC | MBC | |
| C17H17NO4 ( | > 10.0 | >10.0 | >10.0 | >10.0 | >10.0 | >10.0 | >10.0 | >10.0 | >10.0 | >10.0 |
| [Cu(L)(NO3)(H2O)2] ( | >10.0 | >10.0 | >10.0 | >10.0 | 0.5 | >10.0 | 0.5 | >10.0 | 0.5 | >10.0 |
| [Cu(L)2] ( | >10.0 | >10.0 | >10.0 | >10.0 | 0.5 | >10.0 | 0.5 | >10.0 | 0.12 | >10.0 |
| [Cu(L)(OAc)] ( | >10.0 | >10.0 | >10.0 | >10.0 | >10.0 | >10.0 | 0.5 | >10.0 | >10.0 | >10.0 |
| [Cu2 (L)2Cl2(H2O)4] ( | >10.0 | >10.0 | >10.0 | >10.0 | 0.5 | >10.0 | >10.0 | >10.0 | >10.0 | >10.0 |
| [Cu(L)(ClO4)(H2O)] ( | 0.5 | >10.0 | >10.0 | >10.0 | 0.5 | >10.0 | 0.5 | >10.0 | 0.12 | >10.0 |
| Furacillinum | 0.018 | 0.037 | 0.009 | 0.009 | 0.009 | 0.009 | 0.037 | 0.037 | - | - |
| Nystatine | - | - | - | - | - | - | - | - | 0.08 | 0.08 |
E. coli (Escherichia coli, ATCC 25922); S. enteritidis (Salmonella enteritidis); S. aureus (Staphylococcus aureus, ATCC 25923); C. albicans (Candida albicans); a MIC—Minimum inhibitory concentration; b MBC—Minimum bactericide concentration; G(−): Gram-negative bacteria; G(+): Gram-positive bacteria.
Crystallographic data, details of data collection and structure refinement parameters for HL and 6.
| Compound | HL | 6 |
|---|---|---|
| Empirical formula | C17H17NO4 | C68H66Cl2Cu2N4O26S2 |
| Formula weight | 299.32 | 1617.35 |
| Temperature/K | 200 | 293 |
| Crystal system | monoclinic | monoclinic |
| Space group | ||
| 15.4089(7) | 16.7582(11) | |
| 6.4308(3) | 26.2186(13) | |
| 29.8710(16) | 17.9269(12) | |
| α/° | 90.00 | 90.00 |
| β/° | 95.916(4) | 107.710(8) |
| γ/° | 90.00 | 90.00 |
| 2944.2(2) | 7503.4(8) | |
| 8 | 4 | |
| 1.351 | 1.432 | |
| μ/mm−1 | 0.097 | 0.774 |
| Crystal size/mm3 | 0.2 × 0.1 × 0.1 | 0.35 × 0.35 × 0.1 |
| θmin, θ max (°) | 6.22 to 49.42 | 3.92 to 46.52 |
| Reflections collected | 4619 | 30514 |
| Independent reflections | 2404 [ | 10,753 [ |
| Data/restraints/parameters | 2404/0/201 | 10,753/29/942 |
| GOF c | 1.010 | 1.028 |
| 0.0434 | 0.0791 | |
| 0.1020 | 0.2287 | |
| Largest diff. peak/hole/e Å‒3 | 0.11/−0.15 | 0.72/−0.87 |
R1 = Σ||Fo| − |Fc||/Σ|Fo|; wR2 = {Σ[w (Fo2 − Fc2)2] /Σ[w(Fo2)2 ]}1/2; GOF = {Σ[w(Fo2 − Fc2)2] /(n – p)}1/2, where n is the number of reflections and p is the total number of parameters refined.